Please assess the completion status of the following clinical trial:

Trial Title: Determination of the Optimal Dose of Ephedrine in Intraoperative Arterial Hypotension of Newborns and Infants up to 6 Months of Age.

Study Design Characteristics:
- Allocation: RANDOMIZED
- Intervention Model: PARALLEL
- Observational Model: None
- Primary Purpose: TREATMENT
- Time Perspective: None
- Masking: NONE
- Phase: PHASE2
- Number of Arms: 2.0

Eligibility Criteria:
Inclusion Criteria:~* Newborns or infants \< 6 months of age,~* boys and girls,~* premature or not,~* requiring general anesthesia induced by sevoflurane~* who presents during anesthesia a decrease of blood pressure superior to 20% of the basal mBP (measured prior to surgery) despite of vascular filling with sodium chloride 0.9% (10mL/kg during 10 min).~* Written, informed consent obtained from the 2 parents~Exclusion Criteria:~* Allergy to Ephedrine.~* Emergency surgery.~* Patient having previously received other vasopressive amines.~* Use of other indirect sympathomimetic drug such as phenylpropanolamine, phenylephrine, pseudoephedrine and methylphenidate.~* Premedication with clonidine~* Congenital heart disease~* IV-induced anesthesia.

- Gender: ALL
- Minimum Age: None
- Maximum Age: 6 Months
- Healthy Volunteers: f

Study Arms:
- Ephedrine, dose : 0.6, 0.8, 1.0, 1.2 and 1.4 mg/kG (Type: EXPERIMENTAL): Dose escalation: 6 successive cohorts with a maximal increasing dose
- Ephedrine, dose : 0.1 mg/kG, reference dose (Type: ACTIVE_COMPARATOR): Reference dose

Based on this trial design, predict the completion outcome and termination type (if applicable).